Authors:
Chaudhary, KS
Abel, PD
Stamp, GWH
Lalani, EN
Citation: Ks. Chaudhary et al., Differential expression of cell death regulators in response to thapsigargin and adriamycin in Bcl-2 transfected DU145 prostatic cancer cells, J PATHOLOGY, 193(4), 2001, pp. 522-529
Authors:
Madaan, S
Abel, PD
Chaudhary, KS
Hewitt, R
Stott, MA
Stamp, GWH
Lalani, EN
Citation: S. Madaan et al., Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment, BJU INT, 86(6), 2000, pp. 736-741
Authors:
Wong, WM
Stamp, GWH
Elia, G
Poulsom, R
Wright, NA
Citation: Wm. Wong et al., Proliferative populations in intestinal metaplasia: evidence of deregulation in Paneth and goblet cells, but not endocrine cells, J PATHOLOGY, 190(1), 2000, pp. 107-113
Authors:
Pandha, HS
Martin, LA
Rigg, A
Hurst, HC
Stamp, GWH
Sikora, K
Lemoine, NR
Citation: Hs. Pandha et al., Genetic prodrug activation therapy for breast cancer: A phase I clinical trial of erbB-2-directed suicide gene expression, J CL ONCOL, 17(7), 1999, pp. 2180-2189
Authors:
Wang, Q
Stamp, GWH
Powell, S
Abel, P
Laniado, M
Mahony, C
Lalani, EN
Waxman, J
Citation: Q. Wang et al., Correlation between androgen receptor expression and FGF8 mRNA levels in patients with prostate cancer and benign prostatic hypertrophy, J CLIN PATH, 52(1), 1999, pp. 29-34
Authors:
Koumarianou, AA
Hudson, M
Williams, R
Epenetos, AA
Stamp, GWH
Citation: Aa. Koumarianou et al., Development of a novel bi-specific monoclonal antibody approach for tumourtargeting, BR J CANC, 81(3), 1999, pp. 431-439
Authors:
Stubbs, AP
Abel, PD
Golding, M
Bhangal, G
Wang, Q
Waxman, J
Stamp, GWH
Lalani, EN
Citation: Ap. Stubbs et al., Differentially expressed genes in hormone refractory prostate cancer - Association with chromosomal regions involved with genetic aberrations, AM J PATH, 154(5), 1999, pp. 1335-1343